Keywords
brain-derived neurotrophic factor
National Institutes of Health Stroke Scale
How to Cite
Abstract
The article presents the results of our research on determining the content of Brain-Derived Neurotrophic Factor (BDNF) in the blood serum of healthy individuals and patients with Acute Ischemic Stroke (AIS), depending on the severity of the disease as assessed by the National Institutes of Health Stroke Scale (NIHSS). The neurotrophin content in the blood serum of 30 practically healthy individuals and 85 patients with acute ischemic stroke was studied using an immunoenzymatic method. Using the NIHSS scale, patients were divided into three groups depending on the severity of their neurological symptoms. The group I included 30 patients (10 women and 20 men) with scores ranging from 1 to 5. The group II consisted of 32 patients (6 women and 26 men) with scores ranging from 6 to 13. The group III consisted of 23 patients (11 women and 12 men) with scores ranging from 14 to 20. A statistically significant decrease in the content of brain-derived neurotrophic factor in the blood serum of patients with acute ischemic stroke was observed depending on the severity of the disease. The more severe the stroke, the lower the BDNF content in the patients' blood: compared to healthy persons, the neurotrophin content in patients in group I decreased by 22.6%, and in patients in group II by 39.4%. Patients with the most severe course of acute ischemic stroke experienced the greatest decrease in serum BDNF levels, at 816 %, compared to healthy individuals. According to the study, the brain's neurotrophic factor is an early biochemical marker of trophic dysregulation. This results in impaired growth, survival, and recovery of neurons due to acute ischemic stroke.
Keywords: acute ischemic stroke, brain-derived neurotrophic factor, National Institutes of Health Stroke Scale.
References
Palachai N, Supawat A, Kongsui R, Klimaschewski L, Jittiwat J. Galangin's Neuroprotective Role: Targeting Oxidative Stress, Inflammation, and Apoptosis in Ischemic Stroke in a Rat Model of Permanent Middle Cerebral Artery Occlusion. Int J Mol Sci. 2025;26(5):1847. DOI: 10.3390/ijms26051847. PMID: 40076473.
Salaudeen MA, Bello N, Danraka RN, Ammani ML. Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones. Biomolecules. 2024;14(3):305. DOI: 10.3390/biom14030305. PMID: 38540725.
Shkrobot S, Budarna O, Duve K, Tkachuk N. Stroke in young adults: etiopathogenetic mechanisms (bibliosemantic analysis). A clinical case from personal practice. Int Neurol J. 2025;21(3):207-17. DOI: 10.22141/2224-0713.21.3.2025.1176.
Bersano A, Gatti L. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci. 2023;24(19):14848. DOI: 10.3390/ijms241914848. PMID: 37834297.
Yang J, Yang J, Luo Y, Ran D, Xia R, Zheng Q, et al. Nrf1 Reduces COX-2 Expression and Maintains Cellular Homeostasis After Cerebral Ischemia/Reperfusion by Targeting IL-6/TNF-α Protein Production. J Neuroimmune Pharmacol. 2024;19(1):41. DOI: 10.1007/s11481-024-10136-8. PMID: 39103507.
Li Z, Xiao G, Wang H, He S, Zhu Y. A preparation of Ginkgo biloba L. leaves extract inhibits the apoptosis of hippocampal neurons in post-stroke mice via regulating the expression of Bax/Bcl-2 and Caspase-3. J Ethnopharmacol. 2021;280:114481. DOI: 10.1016/j.jep.2021.114481. PMID: 34343651.
Chang X, He Y, Liu Y, Fei J, Qin X, Song B, et al. Serum brain derived neurotrophic factor levels and post-stroke depression in ischemic stroke patients. J Affect Disord. 2024;361:341-7. DOI: 10.1016/j.jad.2024.06.050. PMID: 38897298.
Bejot Y, Prigent-Tessier A, Cachia C, Giroud M, Mossiat C, Bertrand N, et al. Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats. Neurochem Int. 2011;58(1):102-11. DOI: 10.1016/j.neuint.2010.10.019. PMID: 21074587.
Mourao AM, Vicente LCC, Abreu MNS, Vale Sant'Anna R, Vieira ELM, de Souza LC, et al. Plasma Levels of Brain-Derived Neurotrophic Factor are Associated with Prognosis in the Acute Phase of Ischemic Stroke. J Stroke Cerebrovasc Dis. 2019;28(3):735-40. DOI: 10.1016/j.jstrokecerebrovasdis.2018.11.013. PMID: 30522804.
Overberg LT, Lugg EF, Gaarder M, Langhammer B, Thommessen B, Rønning OM, et al. Plasma levels of BDNF and EGF are reduced in acute stroke patients. Heliyon. 2022;8(6):e09661. DOI: 10.1016/j.heliyon.2022.e09661. PMID: 35756121
Pawluk H, Wozniak A, Grzesk G, Kolodziejska R, Kozakiewicz M, Kopkowska E, et al. The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke. Clin Interv Aging. 2020;15:469-84. DOI: 10.2147/CIA.S233909. PMID: 32273689.
Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787-95. DOI: 10.1172/JCI59643. PMID: 22378047.
Dimitrova-Shumkovska J, Krstanoski L, Veenman L. Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update. Cells. 2020;9(4):870. DOI: 10.3390/cells9040870. PMID: 32252470.
Price CJ, Wang D, Menon DK, Guadagno JV, Cleij M, Fryer T, et al. Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke. 2006;37(7):1749-53. DOI: 10.1161/01.STR.0000226980.95389.0b. PMID: 16763188.
Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, et al. BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol Aging. 2008;29(5):789-92. DOI: 10.1016/j.neurobiolaging.2006.11.021. PMID: 17222482.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.